Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Craig C Earle
Affiliation
Odette Cancer Centre
ORCID
Career Start Year
1996
Papers
384
H Index
76
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
32943469
The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis.
BMJ Support Palliat Care
2023
37581543
Hospital encounters and associated costs of prostate evaluation for clinically important disease MRI vs. standard evaluation procedures (PRECISE) study from a provincial-payer perspective.
Can Urol Assoc J
2023
37160325
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort study.
CMAJ Open
2023
37456246
Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study.
Front Oncol
2023
36999965
Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilization.
Cancer Med
2023
36999960
Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: A population-based cohort study.
Cancer Med
2023
36626169
Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in Canada.
JAMA Netw Open
2023
36512739
Use of Instrumental Variable Analyses for Evaluating Comparative Effectiveness in Empirical Applications of Oncology: A Systematic Review.
J Clin Oncol
2023
36423804
The Effect of Specialized Palliative Care on End-of-Life Care Intensity in AYAs with Cancer.
J Pain Symptom Manage
2023
36763927
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes.
JCO Oncol Pract
2023
36863956
Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival.
Clin Oncol (R Coll Radiol)
2023
33619220
Early palliative care and quality of dying and death in patients with advanced cancer.
BMJ Support Palliat Care
2023
34279132
Breast Density and Risk of Interval Cancers: The Effect of Annual Versus Biennial Screening Mammography Policies in Canada.
Can Assoc Radiol J
2022
35640988
Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.
CMAJ Open
2022
35758620
Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer.
JNCI Cancer Spectr
2022
36351330
Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake.
J Natl Compr Canc Netw
2022
36290888
Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic?
Curr Oncol
2022
35190844
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes.
Ann Hematol
2022
35226087
Comparative Effectiveness and Safety of Pertuzumab and Trastuzumab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy for Treatment of Metastatic Breast Cancer.
JAMA Netw Open
2022
35201264
Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer.
JAMA Oncol
2022
35079907
Reply to K. Kajiwara et al. concerning "Caregiver bereavement outcomes in advanced cancer: associations with quality of death and patient age".
Support Care Cancer
2022
35104788
Incident Cancer Detection During the COVID-19 Pandemic.
J Natl Compr Canc Netw
2022
34499215
Caregiver bereavement outcomes in advanced cancer: associations with quality of death and patient age.
Support Care Cancer
2022
34456106
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces.
Clin Oncol (R Coll Radiol)
2022
32956005
Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia.
JCO Oncol Pract
2021
33853916
Building capacity for palliative care delivery in primary care settings: Mixed-methods evaluation of the INTEGRATE Project.
Can Fam Physician
2021
33538782
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
2021
33687618
The cost of chemotherapy administration: a systematic review and meta-analysis.
Eur J Health Econ
2021
34880055
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
BMJ
2021
34898572
Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise.
Curr Oncol
2021
34728119
The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
Breast
2021
34779846
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer.
JAMA Netw Open
2021
34659808
Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada.
J Thorac Dis
2021
34478676
Transforming Canada's role in global cancer control.
Lancet Oncol
2021
34128429
Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+).
Palliat Med
2021
34269805
High-Intensity vs Low-Intensity Knowledge Translation Interventions for Surgeons and Their Association With Process and Outcome Measures Among Patients Undergoing Rectal Cancer Surgery.
JAMA Netw Open
2021
34212111
Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces.
MDM Policy Pract
2021
34097441
Impact of Palliative Care Involvement on End-of-Life Care Patterns Among Adolescents and Young Adults With Cancer: A Population-Based Cohort Study.
J Clin Oncol
2021
33105030
Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada.
Int J Cancer
2021
33360327
Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy.
Cancer Treat Res Commun
2021
30972631
Are We Choosing Surveillance Imaging in Gastric and Pancreatic Cancers Wisely? A Population-Based Study.
J Gastrointest Cancer
2020
33704191
Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response.
Curr Oncol
2020
31910386
High-Cost Patients and Preventable Spending: A Population-Based Study.
J Natl Compr Canc Netw
2020
31724340
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.
Cancer Med
2020
32020357
Integration of patient-reported outcomes (PROs) for personalized symptom management in "real-world" oncology practices: a population-based cohort comparison study of impact on healthcare utilization.
Support Care Cancer
2020
31834527
Economic impacts of care by high-volume providers for non-curative esophagogastric cancer: a population-based analysis.
Gastric Cancer
2020
31860138
Value assessment of oncology drugs using a weighted criterion-based approach.
Cancer
2020
31944866
Operationalizing Outpatient Palliative Care Referral Criteria in Lung Cancer Patients: A Population-Based Cohort Study Using Health Administrative Data.
J Palliat Med
2020
32036719
Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'.
Leuk Lymphoma
2020
32005036
Does early palliative identification improve the use of palliative care services?
PLoS One
2020
1 - 50 of 384
Column Actions
Search
Recommended Authors
Edward Christopher Dee
Memorial Sloan Kettering Cancer Center
Career Start Year
2017
Number of shared co-authors
2
Jessica A Lavery
Memorial Sloan Kettering Cancer Center
Career Start Year
2015
Number of shared co-authors
2
Ian Solsky
Wake Forest University
Career Start Year
2015
Number of shared co-authors
1
Donna R Rivera
Oncology Center of Excellence
Career Start Year
2012
Number of shared co-authors
3
Lawson Eng
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
2011
Number of shared co-authors
3
Christine Massey
Princess Margaret Cancer Centre
Career Start Year
2010
Number of shared co-authors
2
Laura A Levit
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year
2010
Number of shared co-authors
1
Erin E Hahn
Kaiser Permanente
Career Start Year
2008
Number of shared co-authors
0
Suja S Rajan
UTHealth School of Public Health
Career Start Year
2008
Number of shared co-authors
0
Sunita Ghosh
Cross Cancer Institute
Career Start Year
2006
Number of shared co-authors
0
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Career Start Year
2005
Number of shared co-authors
1
Kathryn J Ruddy
Mayo Clinic
Career Start Year
2004
Number of shared co-authors
3
Steven B Zeliadt
VA Puget Sound Healthcare System
Career Start Year
2003
Number of shared co-authors
0
June M McKoy
Feinberg School of Medicine, Northwestern University
Career Start Year
2003
Number of shared co-authors
1
Nora Horick
Massachusetts General Hospital
Career Start Year
2003
Number of shared co-authors
3
Nancy Roach
Marti Nelson Cancer Foundation
Career Start Year
2003
Number of shared co-authors
1
Sharon H Giordano
The University of Texas MD Anderson Cancer Center
Career Start Year
2002
Number of shared co-authors
4
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Career Start Year
2001
Number of shared co-authors
2
Thomas J George
UF Health Cancer Center
Career Start Year
1998
Number of shared co-authors
4
Reina Haque
Southern California Permanente Medical Group
Career Start Year
1998
Number of shared co-authors
1
Yong-Fang Kuo
University of Texas Medical Branch at Galveston
Career Start Year
1997
Number of shared co-authors
0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year
1997
Number of shared co-authors
5
Arash Naeim
University of California los angeles
Career Start Year
1994
Number of shared co-authors
0
Paul J Novotny
Mayo Clinic
Career Start Year
1994
Number of shared co-authors
3
Jeffrey Peppercorn
Massachusetts General Hospital, Harvard Medical School
Career Start Year
1993
Number of shared co-authors
2
Michael Brundage
Cancer Centre of Southeastern Ontario
Career Start Year
1993
Number of shared co-authors
5
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Career Start Year
1992
Number of shared co-authors
3
Jeff A Sloan
Mayo Clinic
Career Start Year
1991
Number of shared co-authors
4
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Career Start Year
1987
Number of shared co-authors
1
Lynne Penberthy
National Cancer Institute
Career Start Year
1983
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Bridget A Neville
Brigham and Women's Hospital
Co-authored papers
44
Antonio C Wolff
Co-authored papers
6
Jonathan C Irish
Princess Margaret Cancer Centre
Co-authored papers
6
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers
6
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers
6
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Co-authored papers
6
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers
5
Khaled El Emam
CHEO Research Institute
Co-authored papers
5
Saeed Samet
Memorial University of Newfoundland
Co-authored papers
5
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers
4
Deborah Schrag
Memorial-Sloan Kettering Cancer Center
Co-authored papers
4
Murat Kantarcioglu
University of Texas at Dallas
Co-authored papers
4
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers
4
Mireille Jacobson
Co-authored papers
4
Endel J Orav
Brigham and Women's Hospital
Co-authored papers
3
Eric P Winer
Dana-Farber Cancer Institute
Co-authored papers
3
George Tomlinson
University Health Network
Co-authored papers
3
Inna Y Gong
University of Toronto
Co-authored papers
3
Gary Rodin
Princess Margaret Cancer Centre (University Health Network)
Co-authored papers
3
Al B Benson
Northwestern University Feinberg School of Medicine
Co-authored papers
3
Alistair J O'Malley
The Dartmouth Institute, Geisel School of Medicine at Dartmouth
Co-authored papers
2
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers
2
Anthony V D'Amico
Duke University Medical Center
Co-authored papers
2
Mark N Levine
Juravinski Hospital and Cancer Center
Co-authored papers
2
Luk Arbuckle
Children's Hospital of Eastern Ontario (CHEO) Research Institute
Co-authored papers
2
Liam Peyton
University of Ottawa
Co-authored papers
2
David L Buckeridge
McGill University
Co-authored papers
2
Jagadish Rangrej
Ontario Ministry of Health and Long-Term Care
Co-authored papers
2
Elizabeth Jonker
Childrens Hospital of Eastern Ontario Research Institute
Co-authored papers
2
Jun Hu
Co-authored papers
2
1 - 30